ADC Therapeutics SA Other Comprehensive Income Net Of Tax Exchange Differences On Translation
ADC Therapeutics SA (ADCT) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -$293.00 thousand for the 3-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2023-11-07
- ADC Therapeutics SA other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-09-30 was -$293.00K.
- ADC Therapeutics SA other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-06-30 was $169.00K.
- ADC Therapeutics SA other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-03-31 was $141.00K.
- ADC Therapeutics SA other comprehensive income net of tax exchange differences on translation for the quarter ending 2022-12-31 was $486.00K, a 2109.09% increase year-over-year.
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 3 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 6 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 9 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$293.00K 6-K · filed 2023-11-07 | -$124.00K derived: sum of 2 quarters · filed 2023-11-07 | $17.00K 6-K · filed 2023-11-07 | $503.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | $169.00K 6-K · filed 2023-08-08 | $310.00K 6-K · filed 2023-08-08 | $796.00K derived: sum of 3 quarters · filed 2023-08-08 | $312.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | $141.00K 6-K · filed 2023-05-09 | $627.00K derived: sum of 2 quarters · filed 2023-05-09 | $143.00K derived: sum of 3 quarters · filed 2023-11-07 | -$240.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $486.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $2.00K derived: sum of 2 quarters · filed 2023-11-07 | -$381.00K derived: sum of 3 quarters · filed 2023-11-07 | -$539.00K 20-F · filed 2023-03-15 |
| 2022-09-30 | -$484.00K 6-K · filed 2023-11-07 | -$867.00K derived: sum of 2 quarters · filed 2023-11-07 | -$1.02M 6-K · filed 2023-11-07 | -$1.00M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$383.00K 6-K · filed 2023-08-08 | -$541.00K 6-K · filed 2023-08-08 | -$519.00K derived: sum of 3 quarters · filed 2023-08-08 | -$659.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$158.00K 6-K · filed 2023-05-09 | -$136.00K derived: sum of 2 quarters · filed 2023-05-09 | -$276.00K derived: sum of 3 quarters · filed 2023-05-09 | -$256.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $22.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$118.00K derived: sum of 2 quarters · filed 2023-03-15 | -$98.00K derived: sum of 3 quarters · filed 2023-03-15 | -$62.00K 20-F · filed 2023-03-15 |
| 2021-09-30 | -$140.00K 6-K · filed 2022-11-08 | -$120.00K derived: sum of 2 quarters · filed 2022-11-08 | -$84.00K 6-K · filed 2022-11-08 | $156.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $20.00K 6-K · filed 2022-08-09 | $56.00K 6-K · filed 2022-08-09 | $296.00K derived: sum of 3 quarters · filed 2023-03-15 | $447.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $36.00K 6-K · filed 2022-05-09 | $276.00K derived: sum of 2 quarters · filed 2023-03-15 | $427.00K derived: sum of 3 quarters · filed 2023-03-15 | $414.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $240.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $391.00K derived: sum of 2 quarters · filed 2023-03-15 | $378.00K derived: sum of 3 quarters · filed 2023-03-15 | $176.00K 20-F · filed 2023-03-15 |
| 2020-09-30 | $151.00K 6-K · filed 2021-11-02 | $138.00K derived: sum of 2 quarters · filed 2021-11-02 | -$64.00K 6-K · filed 2021-11-02 | |
| 2020-06-30 | -$13.00K 6-K · filed 2021-08-03 | -$215.00K 6-K · filed 2021-08-03 | ||
| 2020-03-31 | -$202.00K 6-K · filed 2021-05-06 | |||
| 2019-12-31 | $112.00K 20-F · filed 2022-03-17 | |||
| 2018-12-31 | -$79.00K 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |